Corbus Pharmaceuticals Q3 EPS $(1.81) Misses $(1.20) Estimate
Benzinga Newsdesk 8 hours ago
NewsEarningsEarnings Misses
Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.81) per share which missed the analyst consensus estimate of $(1.20) by 50.83 percent. This is a 4.74 percent increase over losses of $(1.90) per
Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.81) per share which missed the analyst consensus estimate of $(1.20) by 50.83 percent. This is a 4.74 percent increase over losses of $(1.90) per share from the same period last year.